| Mechanisms of disease: Pre-eclampsia | Nature Clinical Practice Nephrology | 2005 | 217 |
| Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies | Thrombosis and Haemostasis | 2005 | 75 |
| Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation | American Journal of Transplantation | 2005 | 62 |
| Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia | Kidney International | 2005 | 31 |
| High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus | Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences | 2005 | 30 |
| Generic cyclosporine formulations: more open questions than answers | Transplant International | 2005 | 25 |
| Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy | Nephrology Dialysis Transplantation | 2005 | 22 |
| Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? | Journal of the American Society of Nephrology: JASN | 2005 | 22 |
| Hyperuricemia in kidney transplantation | Contributions To Nephrology | 2005 | 20 |
| Natural versus adaptive regulatory T cells | Contributions To Nephrology | 2005 | 20 |
| Pathophysiology of disease progression in proteinuric nephropathies | Kidney International | 2005 | 20 |
| Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation | Clinica Chimica Acta | 2005 | 15 |
| The future of renoprotection | Kidney International | 2005 | 15 |
| Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago? | Kidney International | 2005 | 14 |
| Lipid oxidative stress and the anti-inflammatory properties of statins and ACE inhibitors | Journal of Renal Nutrition | 2005 | 12 |
| Cyclosporine formulation and Kaposi's sarcoma after renal transplantation | Transplantation | 2005 | 12 |
| Emerging drugs for diabetic nephropathy | Expert Opinion on Emerging Drugs | 2005 | 8 |
| Autologous stem cell and kidney transplantation for primary amyloidosis associated with ESRD: which should come first? | American Journal of Transplantation | 2005 | 5 |
| Chronic allograft nephropathy. A multiple approach to target nonimmunological factors | Contributions To Nephrology | 2005 | 4 |
| Kidney prevention recipes for your office practice | Kidney International | 2005 | 1 |
| The scientific care for prevention: an overview | Kidney International | 2005 | |
| The Bergamo Kidney Transplant Program | Clinical Transplants | 2005 | |
